HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masako Ito Selected Research

alfacalcidol

7/2020Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study.
7/2020Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
11/2011[Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure].
10/2011A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
9/2011Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
7/2011[Diagnostic imaging of treatment in osteoporosis; new active vitamin D].
6/2009The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
1/2005Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
4/2002Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masako Ito Research Topics

Disease

35Osteoporosis
01/2021 - 04/2002
24Bone Resorption
01/2021 - 04/2002
5Metabolic Bone Diseases (Osteopenia)
05/2014 - 07/2007
4Neoplasms (Cancer)
05/2022 - 12/2012
4Postmenopausal Osteoporosis
01/2019 - 12/2006
2Arthritis (Polyarthritis)
07/2022 - 04/2014
2Opioid-Induced Constipation
05/2022 - 11/2021
2Inflammation (Inflammations)
07/2018 - 09/2010
2Stress Fractures (Stress Fracture)
01/2016 - 07/2014
2Pulmonary Hypertension
10/2011 - 06/2010
2Hypoxia (Hypoxemia)
07/2011 - 06/2010
1Experimental Arthritis
07/2022
1Rheumatoid Arthritis
07/2022
1Synovitis
07/2022
1Brain Diseases (Brain Disorder)
04/2019
1Seizures (Absence Seizure)
04/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2018
1Hip Fractures (Intertrochanteric Fractures)
01/2018
1Kidney Diseases (Kidney Disease)
09/2014
1Renal Insufficiency (Renal Failure)
09/2014
1Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
09/2014
1Congenital Abnormalities (Deformity)
07/2014
1Spinal Curvatures (Spinal Curvature)
06/2014
1Mouth Neoplasms (Oral Cancer)
05/2013
1Osteoarthritis
07/2012
1Hip Osteoarthritis (Coxarthrosis)
07/2012
1Mental Disorders (Mental Disorder)
03/2012
1Vascular Remodeling
10/2011
1Wrist Fractures
10/2011
1Osteoporotic Fractures
10/2011
1Pulmonary Arterial Hypertension
06/2010

Drug/Important Bio-Agent (IBA)

9alfacalcidolIBA
07/2020 - 04/2002
7Teriparatide (Parathar)FDA Link
01/2021 - 01/2004
5GlucocorticoidsIBA
07/2020 - 01/2005
4Ibandronic Acid (Boniva)FDA Link
01/2021 - 08/2013
4Diphosphonates (Bisphosphonates)IBA
05/2018 - 03/2003
4Biomarkers (Surrogate Marker)IBA
11/2008 - 09/2006
3CytokinesIBA
07/2022 - 08/2006
3Pharmaceutical PreparationsIBA
07/2020 - 11/2008
3eldecalcitol (ED 71)IBA
07/2020 - 10/2011
3Alkaline PhosphataseIBA
07/2018 - 11/2008
3Collagen Type I (Type I Collagen)IBA
07/2018 - 12/2006
3MineralsIBA
01/2018 - 01/2004
3DenosumabFDA Link
12/2017 - 05/2013
3Risedronic Acid (Actonel)FDA LinkGeneric
08/2013 - 09/2006
3Parathyroid Hormone (Parathormone)IBA
09/2012 - 12/2005
3OsteoprotegerinIBA
12/2011 - 08/2006
3Vitamin DFDA LinkGeneric
10/2011 - 04/2002
3deoxypyridinolineIBA
11/2008 - 12/2006
2AntibodiesIBA
07/2022 - 05/2013
2naldemedineIBA
05/2022 - 11/2021
2AcidsIBA
01/2021 - 11/2008
2YM 529IBA
07/2020 - 05/2010
2RANK LigandIBA
12/2017 - 06/2007
2Phosphates (Orthophosphate)IBA
09/2014 - 12/2010
2SteroidsIBA
09/2014 - 01/2011
2LigandsIBA
05/2013 - 12/2011
2Therapeutic UsesIBA
10/2011 - 06/2009
2CalciumIBA
12/2010 - 06/2009
2Estrogens (Estrogen)FDA Link
03/2009 - 04/2002
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2007 - 12/2006
2Alendronate (Alendronate Sodium)FDA LinkGeneric
12/2006 - 01/2005
1Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA
07/2022
1KN 93IBA
07/2022
1Opioid Analgesics (Opioids)IBA
11/2021
1Narcotic Antagonists (Opioid Antagonists)IBA
11/2021
1tartaric acid (tartrate)FDA Link
01/2021
1Metronidazole (Metric)FDA LinkGeneric
04/2019
1elcatoninIBA
01/2019
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
07/2018
1Glycoproteins (Glycoprotein)IBA
07/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1Zoledronic Acid (Zometa)FDA Link
01/2018
1Monoclonal AntibodiesIBA
12/2017
1lanthanum carbonate (Fosrenol)FDA Link
09/2014
1calcium phosphateIBA
09/2014
1salicylhydroxamic acid (SHAM)IBA
09/2014
1FilaminsIBA
06/2014
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
05/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2013
1RNA (Ribonucleic Acid)IBA
12/2011
1Tyrosine Kinase InhibitorsIBA
10/2011
1Cholecalciferol (Vitamin D3)FDA Link
10/2011
1Phosphotransferases (Kinase)IBA
10/2011
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
07/2011
1Calcitriol (Calcijex)FDA LinkGeneric
07/2011
1Pregnane X ReceptorIBA
12/2010
1Chemokine ReceptorsIBA
09/2010
1ChemokinesIBA
09/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2010
1Semaxinib (SU5416)IBA
06/2010

Therapy/Procedure

5Therapeutics
01/2021 - 12/2004
3Injections
01/2017 - 03/2013
3Synchrotrons
01/2016 - 07/2012
3Ovariectomy (Oophorectomy)
04/2014 - 07/2007
2Subcutaneous Injections
06/2010 - 01/2004
1Activities of Daily Living (ADL)
07/2014
1Palliative Care (Palliative Therapy)
12/2012
1Anesthesia
03/2012
1Bed Rest (Bedrest)
01/2012